Pharma News
-
Astellas, Merck enter co-promotion deal in Japan
Pharma | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2013
Singapore: Astellas Pharma and MSD KK, the Japan unit of US pharma giant Merck, have entered into a co-promotion agreeme...Read more
-
BGI-Shenzhen extends tender offer for Complete Genomics
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: BGI-Shenzhen (BGI) announced that it, through its wholly owned subsidiary Beta Acquisition, has extended its...Read more
-
Astellas, UCB announce approval of Cimzia in Japan
Pharma | News | By BioSpectrum Bureau | 0 Comment | 01 Jan, 2013
Singapore: Astellas Pharma and UCB announced that UCB Japan has received marketing approval from the Japanese Ministry ...Read more
-
NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds
Pharma | Regulatory | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, ant...Read more
-
Frost & Sullivan awards life science leaders
Pharma | News | By BioSpectrum Bureau | 0 Comment | 01 Oct, 2012
Mumbai: The 4th Annual Frost & Sullivan India Healthcare Excellence Awards 2012, were held in Mumbai to recognize co...Read more
-
Biostar signs another $3 mn military contract within a month
Pharma | News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2012
Singapore: China-based Biostar Pharmaceuticals signed a one-year agreement, valued at approximately $3.0 million, to man...Read more
-
FDA warns Genentech researcher for trial data validity
Pharma | News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2013
Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular d...Read more
-
Medigene, SynCore expand deal for Veregen
Pharma | News | By BioSpectrum Bureau | 0 Comment | 20 Mar, 2013
Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expa...Read more
-
Ranbaxy may fire 1/3rd of its global sales staff
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 May, 2013
Singapore: Ranbaxy Laboratories is contemplating on slashing its global sales staff by about a third, with a majority of...Read more
-
Aus, NZ progress on joint regulatory agency
Pharma | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2012
Singapore: Ministers from Australia and New Zealand attended the second meeting of the Australia New Zealand Therapeutic...Read more
-
Now 9-yr-old girls can use Cervarix for cancer
Pharma | Regulatory | By BioSpectrum Bureau | 0 Comment | 07 May, 2013
Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, prem...Read more
-
Hiring freeze in pharma industry
Pharma | News | By BioSpectrum Bureau | 0 Comment | 07 Sep, 2012
New Delhi: The overall economic crunch has resulted in companies adopting a cautious approach in their hiring plans. Nau...Read more
-
Sucampo, Abbott launch Amitiza in Japan
Pharma | News | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2012
Singapore: Sucampo Pharmaceuticals and Abbott have launched Amitiza (lubiprostone) in Japan, a prescription medicine for...Read more
-
India clears Mylan's $760 mn acquisition deal
Pharma | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: The Indian Cabinet Committee on Economic Affairs (CCEA) gave its final clearance to US-based Mylan to acquire...Read more
-
Xiangxue Pharma acquires rights for Kinex KX02
Pharma | News | By BioSpectrum Bureau | 0 Comment | 22 May, 2012
Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceut...Read more
-
Pharma | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market fol...Read more
-
Chinese, Hong Kong scientists map H7N9 risk infection
Pharma | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2013
Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production ...Read more
-
AstraZeneca, Alchemia sign $240 mn drug deal
Pharma | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013
Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the...Read more
